Therapeutic Potential of HNF4α in End-stage Liver Disease-Reference-Cited by-同舟云学术

Therapeutic Potential of HNF4α in End-stage Liver Disease

Published:2021-10-02 Issue:3-4 Volume:17 Page:126-135
ISSN:1547-6278
Container-title:Organogenesis
language:en
Short-container-title:Organogenesis

Author:

Diaz-Aragon Ricardo¹,Coard Michael C.¹,Amirneni Sriram¹,Faccioli Lanuza¹,Haep Nils¹,Malizio Michelle R.¹,Motomura Takashi¹,Kocas-Kilicarslan Zehra N.¹,Ostrowska Alina¹²,Florentino Rodrigo M.¹,Frau Carla¹

Affiliation:

1. Department of Pathology, University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania, USA

2. Pittsburgh Liver Research Center, University of Pittsburgh, Pittsburgh, Pennsylvania, USA

Funder

NIH/NIDDK

Publisher

Informa UK Limited

Subject

Transplantation,Developmental Biology,Biomedical Engineering,Embryology

Link

https://www.tandfonline.com/doi/pdf/10.1080/15476278.2021.1994273

Reference82 articles.

1. Background and design of the symptom burden in end-stage liver disease patient-caregiver dyad study

2. Mortality due to cirrhosis and liver cancer in the United States, 1999-2016: observational study

3. Underestimation of Liver-Related Mortality in the United States

4. Treatment of Patients with Cirrhosis

5. Future Economics of Liver Transplantation: A 20-Year Cost Modeling Forecast and the Prospect of Bioengineering Autologous Liver Grafts

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic insight into the role of nuclear protein HNF4α in liver carcinogenesis;Advances in Protein Chemistry and Structural Biology;2024

2. Disruption of the mouse liver epitranscriptome by long-term aroclor 1260 exposure;Environmental Toxicology and Pharmacology;2023-06

3. Impaired hepatic glucose metabolism and liver-α-cell axis in mice with liver-specific ablation of the Hepatocyte Nuclear Factor 4α (Hnf4a) gene;Metabolism;2023-02